comparemela.com
Home
Live Updates
Pathios Therapeutics Raises $25M in First Close of Series B Financing to Advance First-in-Class Immunotherapy Approach into Clinic : comparemela.com
Pathios Therapeutics Raises $25M in First Close of Series B Financing to Advance First-in-Class Immunotherapy Approach into Clinic
/PRNewswire/ -- Pathios Therapeutics Limited ("Pathios"), a biotech company focused on the development of first-in-class therapies for cancer, today announced...
Related Keywords
United Kingdom ,
United States ,
American ,
Stuart Hughes ,
Tim Brons ,
Tom Mccarthy ,
Leadership Team To ,
Innovation Centre On Milton Park ,
Prnewswire Pathios Therapeutics Limited ,
American Association For Cancer Research ,
Bristol Myers Squibb ,
Stage Company ,
Fundraising Includes New Strategic Investment ,
Continued Support ,
Existing Investors ,
Advance Lead Candidate ,
Expand Leadership Team ,
Pathio Transition ,
Therapeutics Limited ,
Brandon Capital ,
American Association ,
Cancer Research ,
Annual Meeting ,
Pathios Therapeutics ,
Canaan Partners ,
Bristol Myers ,
Innovation Centre ,
Milton Park ,
Grey Wolf Therapeutics ,
Executive Chair ,
Chief Executive ,
Chief Scientific ,
Strategic Partners ,
comparemela.com © 2020. All Rights Reserved.